#LCSM Chat 5/22 Preview: Top 10 Key LC Presentations at ASCO 2014
By Howard (Jack) West, MD
Please join us for the next #LCSM chat on Thursday, May 22, 2014, at 8 PM ET (5 PM Pacific). Our topic will be “Top 10 Key LC Presentations at ASCO 2014.” I’ll be moderating.
Every year, many of the key developments in cancer care are presented at the annual American Society of Clinical Oncology (ASCO) meeting in Chicago at the end of May. This year ASCO will highlight several practice-changing results for lung cancer. Impressively, the most important trials this year focus on treating a broad spectrum of patients: first line treatment of patients with an EGFR mutation, acquired resistance in EGFR mutation-positive patients, the MET mutation as a target, squamous NSCLC, general NSCLC that includes squamous and non-squamous NSCLC, one striking finding in stage III resected NSCLC, and even immediately practice-changing results in small cell lung cancer.
A list limited to ten doesn’t allow me to include some notable trials with negative results, particularly those which we’ve already seen in press releases. And while immunotherapies continue to demonstrate their promise, immunotherapy presentations at ASCO this year don’t break significant new ground, and so didn’t make the “top 10” cut (I expect at least one or two on next year’s top 10 list).
For this chat, I’ll post a new chart every 5 minutes, then people can ask questions and comments about it during the chat. Participants can also comment on other attention-worthy presentations not on my list. You can see my top 10 list slideshare presentation on my cancerGRACE.org blog post here. You can find the entire collection of ASCO abstracts here.
I hope you find the top 10 list provocative and interesting. For more information about how to participate in an #LCSM chat, check out our primer. Remember to add the #LCSM hashtag to your tweets; it’s usually easier to follow or participate if you use http://www.tchat.io/rooms/lcsm or a similar application.
Hope you’ll join us on Twitter Thursday!